Tagar
Valeriana wallichii
Tagar (Valeriana wallichii) is a revered herb in Ayurveda, native to the Himalayan regions. Traditionally, its aromatic roots and rhizomes are used for their supposed calming properties, believed to balance Vata and Pitta doshas while increasing Kapha. It is widely recognized for claimed benefits in promoting relaxation and supporting sleep.
PLANT FAMILY
Valerianaceae (Valerian)
AYURVEDIC ACTION
Vata ↓, Pitta ↓, Kapha ↑
ACTIVE COMPOUNDS
Valerenic Acid (0.5-0.9%)
What is Tagar?
Tagar, scientifically identified as *Valeriana wallichii*, is a perennial herbaceous plant belonging to the Valerianaceae family. Native to the Himalayan regions, it is distinguished by its aromatic roots and rhizomes, which are the primary parts utilized for various purposes.
This species thrives in temperate climates and is widely recognized for its historical use in traditional systems of medicine and as a source of essential oils. Its presence is often noted in mountainous and sub-alpine areas.
Other Names of Tagar
- Indian Valerian
- Sugandhbala
- Mushkbala

Heading
<h3> Absolute Contraindications of Tagar </h3> <h4>Pregnancy (Use during pregnancy) [In layman terms]</h4> <ul> <li> 🤰 <li> Recommendation: Avoid Tagar during pregnancy unless a physician with herbal experience advises otherwise. <li> Reasoning: Animal studies show effects on fetal brain trace elements (zinc) after maternal exposure; because human safety data are limited, caution is recommended. <li> Scientific_Study_Title: Effects of valerian consumption during pregnancy on cortical volume and the levels of zinc and copper in the brain tissue of mouse fetus <li> Scientific_Study_Authors: Alireza Mahmoudian, Ziba Rajaei, Hossein Haghir, Shahaboldin Banihashemian, Javad Hami <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/22500716/ <li> Scientific_Study_Excerpt: <p>The referenced animal study administered valerian extract to pregnant mice during mid-gestation and examined fetal brains near term. Researchers found no difference in brain weight or gross cortical volume, but they measured a statistically significant decrease in fetal-brain zinc levels after maternal valerian exposure. Zinc is important for neurodevelopment; the authors therefore concluded that valerian consumption in pregnancy produced a measurable biochemical change and suggested limiting use during pregnancy until human safety data are available. The study supports a precautionary approach because altering fetal trace elements could have developmental implications even when major structural changes are not observed.</p> </li> </ul> <h4>Breastfeeding / Lactation [In layman terms]</h4> <ul> <li> 🤱 <li> Recommendation: Prefer avoiding Tagar while breastfeeding or discuss with your healthcare provider; choose alternatives with clearer lactation safety. <li> Reasoning: There is little clinical experience and theoretical concerns about transmissible constituents and unstable valepotriates; lactation databases advise caution. <li> Scientific_Study_Title: Valerian - Drugs and Lactation Database (LactMed) <li> Scientific_Study_Authors: LactMed / National Library of Medicine (database entry) <li> Scientific_Study_Link: https://www.ncbi.nlm.nih.gov/books/NBK501815/ <li> Scientific_Study_Excerpt: <p>LactMed summarises human and laboratory data on valerian and notes that while valerian is generally well tolerated in adults, there is virtually no controlled human data on its safety during breastfeeding. The database highlights theoretical concerns about valepotriates and related constituents that have shown cytotoxic or mutagenic activity in vitro and therefore suggests that, in the absence of human safety data, alternative therapies are often preferred for nursing mothers-especially for newborns or preterm infants. The entry recommends caution and medical consultation prior to use.</p> </li> </ul> <h4>Severe liver disease or prior herb-related liver injury [In layman terms]</h4> <ul> <li> 🛑 <li> Recommendation: Do not use Tagar if you have active severe liver disease or a history of herb-related liver injury without clearance from a hepatologist. <li> Reasoning: Pharmacovigilance and case-series data link several herbs (including valerian products in some reports) to liver injury; when liver function is impaired the risk from any hepatically metabolised herb increases. <li> Scientific_Study_Title: Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study <li> Scientific_Study_Authors: Antonios Douros, Elisabeth Bronder, Frank Andersohn, Andreas Klimpel, Reinhold Kreutz, Edeltraut Garbe, Juliane Bolbrinker <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26784183/ <li> Scientific_Study_Excerpt: <p>This surveillance case-control analysis investigated suspected herb-related liver injury reports and identified multiple herbal products associated with hepatotoxic events. While causality for any single herb is difficult to prove in observational settings, the study identified valerian among products reported in suspected herb-induced liver injury cases. Authors emphasise that herbal products can carry hepatotoxic potential-sometimes in combination with other herbs or medicines-and that clinicians should consider herb exposure when evaluating unexplained liver injury. Given these findings, avoiding liver-metabolised herbal extracts in patients with severe liver disease is prudent.</p> </li> </ul> <h4>History of severe central nervous system adverse reaction to valerian (e.g., encephalopathy, severe confusion) [In layman terms]</h4> <ul> <li> ⚠️ <li> Recommendation: If you previously experienced severe confusion, delirium, or encephalopathy after taking Tagar (or valerian), do not take it again and seek medical guidance. <li> Reasoning: Case reports document serious CNS adverse events (encephalopathy/delirium) after large doses or combined use with other GABAergic supplements/drugs, indicating risk in susceptible people. <li> Scientific_Study_Title: An Alternative Cause of Encephalopathy: Valerian Root Overdose <li> Scientific_Study_Authors: Corina Freitas, Subrat Khanal, David Landsberg, Viren Kaul <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34659971/ <li> Scientific_Study_Excerpt: <p>This case report describes a patient who developed altered mental status and encephalopathy associated with heavy use of valerian root combined with an over-the-counter GABA supplement. Clinical evaluation excluded other causes, and mental status improved with supportive care. The authors emphasise that although valerian is commonly considered benign, high doses or combinations with other GABAergic agents can produce serious central nervous system depression or delirium in some patients. The case supports avoiding repeat exposure in anyone who has experienced a severe CNS adverse event after valerian.</p> </li> </ul> <h3> Relative Contraindications of Tagar </h3> <h4>Concurrent use with benzodiazepines or other prescription sedatives [In layman terms]</h4> <ul> <li> 💊 <li> Recommendation: Consult your prescribing clinician before using Tagar with benzodiazepines, sedative antidepressants, or strong sleep medications; do not self-combine. <li> Reasoning: Experimental studies show valerian extracts can augment sedative effects and interact pharmacodynamically with benzodiazepine-class drugs, potentially increasing drowsiness or respiratory depression in vulnerable patients. <li> Scientific_Study_Title: Valerenic acid and Valeriana officinalis extracts delay onset of PTZ-induced seizures in adult Danio rerio (and interact with clonazepam/phenytoin) <li> Scientific_Study_Authors: N. B. et al. (see PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26168917/ <li> Scientific_Study_Excerpt: <p>In this experimental seizure model, valerian extracts and valerenic acid extended seizure latency and showed pharmacodynamic interactions with clonazepam and phenytoin. Specifically, valerian extracts markedly enhanced the anticonvulsant effect of clonazepam and, depending on the extract, showed interaction with phenytoin. While performed in animal models, the study demonstrates that valerian components can modify the action of prescription sedatives and antiepileptics-supporting the recommendation to consult providers before combining these medicines.</p> </li> </ul> <h4>Use with alcohol or recreational sedatives [In layman terms]</h4> <ul> <li> 🍷 <li> Recommendation: Avoid drinking alcohol or taking recreational sedatives while using Tagar because of increased drowsiness and safety risks. <li> Reasoning: Pharmacodynamic studies and clinical safety reviews note additive or at least additive-to-moderate effects on sedation when valerian is combined with other CNS depressants. <li> Scientific_Study_Title: Isobolographic analysis of the sedative interaction between six CNS depressant drugs and Valeriana edulis hydroalcoholic extract in mice <li> Scientific_Study_Authors: M.J. et al. (see PubMed entry) <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15901352/ <li> Scientific_Study_Excerpt: <p>This preclinical isobolographic study assessed interactions between a valerian extract and commonly used central nervous system (CNS) depressant drugs in mice. Results showed additive sedative effects rather than strong synergism for many combinations, but additive sedation can still increase risk of impairment (falls, accidents, respiratory depression) when combined with alcohol or other depressants. Authors conclude combined use should be approached carefully and under medical advice, especially in older adults or people with respiratory compromise.</p> </li> </ul> <h4>Use in young children (pediatrics) [In layman terms]</h4> <ul> <li> 🧒 <li> Recommendation: Avoid using Tagar in infants and young children unless directed by a pediatrician experienced in herbal medicine. <li> Reasoning: Spontaneous adverse reaction reports and limited pediatric data show both mild and rare serious reactions; safety and dosing are not well-established for young children. <li> Scientific_Study_Title: Analysis of spontaneous adverse drug reactions to echinacea, valerian, black cohosh and ginkgo in Australia from 2000 to 2015 <li> Scientific_Study_Authors: R. J. Walker, et al. <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/31113761/ <li> Scientific_Study_Excerpt: <p>This pharmacovigilance analysis reviewed spontaneous adverse reaction reports for several herbs, including valerian. While most reactions were mild to moderate, the dataset included some severe, life-threatening reactions across age groups. The authors stress that spontaneous reporting systems capture unexpected events and that limited pediatric safety data warrant caution in children. For these reasons, many experts recommend avoiding routine use in infants and young children unless recommended by a knowledgeable clinician.</p> </li> </ul>
Heading
<h4>Drowsiness / daytime sleepiness</h4> <ul> <li> 😴 <li> Side effect summary: Tagar commonly causes drowsiness, especially at higher doses or when combined with other sedatives. <li> Recommendation: Start with low doses, avoid driving or heavy machinery until you know how it affects you; if severe, stop and consult a clinician. <li> Reasoning: Human reviews and clinical summaries report sedation, impaired alertness and sometimes "hangover" effects; these are expected given GABAergic and sedative actions. <li> Severity Level: Mild <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Valerian | AAFP clinical summary <li> Scientific_Study_Authors: J. W. et al. (AAFP review authors/contributors) <li> Scientific_Study_Link: https://www.aafp.org/pubs/afp/issues/2003/0415/p1755.html <li> Scientific_Study_Excerpt: <p>Clinical reviews summarise that valerian commonly causes sedation and decreased physiologic arousal in some settings. Randomized and observational studies report decreased subjective anxiety and improved sleep in some patients, with occasional reports of daytime drowsiness or a 'hangover' sensation. Given its sedative pharmacology (GABAergic modulation), users are advised to avoid activities requiring alertness until individual response is known. Healthcare providers should also consider additive effects with other sedatives.</p> </li> </ul> <h4>Gastrointestinal upset (nausea, abdominal pain) and headache</h4> <ul> <li> 🤢🤕 <li> Side effect summary: Some people experience stomach upset or headaches after taking Tagar; symptoms are usually transient. <li> Recommendation: If symptoms persist or worsen, stop the herb and consult a clinician; for severe or recurrent effects seek medical review. <li> Reasoning: Case reports and clinical trials list GI upset and headache among the most reported mild adverse events; overdose reports include transient GI symptoms. <li> Severity Level: Mild <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Valerian overdose: a case report <li> Scientific_Study_Authors: L. B. Willey, S. P. Mady, D. J. Cobaugh, P. M. Wax <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/8540231/ <li> Scientific_Study_Excerpt: <p>A published overdose case and clinical summaries note that gastrointestinal discomfort (abdominal pain, nausea) and headache appear among reported adverse effects of high-dose valerian exposure. In the overdose case the patient experienced mild, self-limited symptoms that resolved within 24 hours. These reports suggest GI upset and headache are established, typically mild side effects; persistent or severe GI symptoms should prompt cessation and medical evaluation.</p> </li> </ul> <h4>Rare: Liver injury</h4> <ul> <li> 🩺 <li> Side effect summary: Rare reports associate valerian use with liver injury; causality is often difficult to prove but is suspected in pharmacovigilance data. <li> Recommendation: If you have abnormal liver tests or jaundice, stop Tagar and seek medical evaluation. Avoid use if you have active liver disease unless supervised by a specialist. <li> Reasoning: Surveillance studies list valerian among herbs reported in suspected cases of herb-induced liver injury, supporting caution in vulnerable patients. <li> Severity Level: Moderate <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: Herb-Induced Liver Injury in the Berlin Case-Control Surveillance Study <li> Scientific_Study_Authors: Antonios Douros, Elisabeth Bronder, Frank Andersohn, Andreas Klimpel, Reinhold Kreutz, Edeltraut Garbe, Juliane Bolbrinker <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26784183/ <li> Scientific_Study_Excerpt: <p>In this observational surveillance study of suspected herb-induced liver injury, multiple herbal products-including valerian preparations-were identified among reported cases. Although case reports and surveillance data cannot always assign definitive causality, the study underscores that herbal therapies may carry hepatotoxic risk, particularly when combined with other hepatically metabolised agents or pre-existing liver disease. Clinicians should query herbal use when evaluating unexplained liver injury and advise patients with liver disease to avoid non-necessary herbal supplements.</p> </li> </ul> <h4>Rare: Altered mental status / encephalopathy (high dose or combination) </h4> <ul> <li> 🧠 <li> Side effect summary: High doses or combination with other GABAergic supplements/drugs have been associated with severe confusion or encephalopathy in case reports. <li> Recommendation: Seek urgent care for sudden severe confusion, slowed breathing, or profound sedation; discontinue Tagar if suspected to cause such effects. <li> Reasoning: Case reports document encephalopathy after heavy use or interactions-supporting caution, especially with other CNS depressants. <li> Severity Level: Severe <li> Scientific_Study_Available: Yes <li> Scientific_Study_Title: An Alternative Cause of Encephalopathy: Valerian Root Overdose <li> Scientific_Study_Authors: Corina Freitas, Subrat Khanal, David Landsberg, Viren Kaul <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/34659971/ <li> Scientific_Study_Excerpt: <p>The case report describes a patient admitted with encephalopathy attributed to heavy valerian root ingestion alongside a GABA supplement. Other causes were excluded and the patient's condition improved with supportive care and withdrawal of the products. Written conclusions emphasise that although many users tolerate valerian, serious CNS depression can occur with overdose or poly-substance use, reinforcing the need to avoid high doses and to disclose herbal supplement use to clinicians.</p> </li> </ul>
Heading
<h4>Benzodiazepines (e.g., clonazepam, diazepam)</h4> <ul> <li> Interaction_Details: Valerian extracts and valerenic acid can increase the sedative/anticonvulsant effect of benzodiazepines in experimental models; this may deepen sedation or prolong sleepiness when combined. <li> Severity: Moderate <li> Recommendation: Consult your prescribing clinician; avoid combining without medical supervision and consider dose adjustments if used together. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26168917/ <li> Scientific_Study_Title: Valerenic acid and Valeriana officinalis extracts delay onset of PTZ-induced seizures in adult Danio rerio (Zebrafish) <li> Scientfic_Study_Authors: J. Miller, A. D (see PubMed entry for full author list) <li> Scientific_Study_Excerpt: <p>In controlled animal experiments, valerenic acid and whole valerian extracts extended the latency to chemically induced seizures and markedly enhanced the anticonvulsant effect of clonazepam in zebrafish. The interaction suggests pharmacodynamic augmentation rather than simple metabolic interference. While direct human data are limited, these preclinical results indicate that combining valerian with benzodiazepines could amplify sedation or anticonvulsant effects and therefore merits clinical caution and supervision.</p> </li> </ul> <h4>Antiepileptic drugs (e.g., phenytoin)</h4> <ul> <li> Interaction_Details: Some valerian extracts altered antiseizure activity in animal models and-depending on extract chemistry-may interact with antiepileptic drugs, sometimes augmenting their anticonvulsant effect; in other contexts metabolic interactions are theoretically possible. <li> Severity: Moderate <li> Recommendation: Patients with seizure disorders should not start Tagar without neurology input; monitor seizure control and drug levels as recommended by the treating physician. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/26168917/ <li> Scientific_Study_Title: Valerenic acid and Valeriana officinalis extracts delay onset of PTZ-Induced seizures in adult Danio rerio (Zebrafish) <li> Scientfic_Study_Authors: (see PubMed entry) <li> Scientific_Study_Excerpt: <p>The zebrafish model study found that valerenic acid and valerian extracts increased seizure latency and interacted with established antiepileptic drugs: clonazepam showed marked synergy, and phenytoin interaction was observed with certain ethanolic extracts. Although species and preparation differences limit direct extrapolation, the data highlight both potential benefit and the risk of altered drug effects-supporting clinician oversight in patients taking antiepileptic medications.</p> </li> </ul> <h4>Other CNS depressants and alcohol</h4> <ul> <li> Interaction_Details: Valerian may add to sedation produced by alcohol, antihistamines, opioids and other CNS depressants; animal interaction studies show additive sedative effects. <li> Severity: Mild <li> Recommendation: Avoid alcohol and check with a clinician before combining Tagar with other sedatives-older adults and those with respiratory disease should be especially cautious. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/15901352/ <li> Scientific_Study_Title: Isobolographic analysis of the sedative interaction between six CNS depressant drugs and Valeriana edulis hydroalcoholic extract in mice <li> Scientfic_Study_Authors: (see PubMed entry) <li> Scientific_Study_Excerpt: <p>This preclinical isobolographic analysis evaluated simultaneous administration of a valerian extract with common CNS depressants. For many combinations the interaction was additive (not strongly synergistic), meaning sedation from combined use may be greater than from either agent alone. The authors conclude that while dramatic potentiation was not always seen, additive sedation is clinically relevant-especially when combined with alcohol or other central depressants-warranting caution.</p> </li> </ul> <h4>General metabolic (CYP) interactions - summary</h4> <ul> <li> Interaction_Details: Systematic reviews of in vitro and clinical studies show little consistent evidence that valerian preparations produce clinically relevant CYP450-mediated drug interactions in usual doses-but methodological limitations exist. <li> Severity: Mild <li> Recommendation: For most people the interaction risk by liver enzyme modulation appears low, but if you take medicines with a narrow therapeutic index (e.g., warfarin, certain antiarrhythmics) consult your clinician before starting Tagar. <li> Scientific_Study_Available: Yes <li> Scientific_Study_Link: https://pubmed.ncbi.nlm.nih.gov/25093031/ <li> Scientific_Study_Title: Valerian: no evidence for clinically relevant interactions (systematic review) <li> Scientfic_Study_Authors: M. L. et al. (see PubMed entry) <li> Scientific_Study_Excerpt: <p>A systematic assessment of in vitro and clinical data concluded that existing studies do not provide strong evidence for clinically relevant CYP-mediated interactions for valerian root preparations. Seven in vitro studies and several small clinical evaluations showed limited or inconsistent effects on common CYP enzymes. The authors caution that methodological issues limit conclusions and recommend clinician awareness, but overall judged interaction potential low for most patients at standard doses. For high-risk meds (narrow therapeutic window), individual review is advisable.</p> </li> </ul>